Body and blood: Chimeras in medicine
What does an ancient Greek monster have to do with treating cancer? As it turns out, quite a lot.
Mar 19, 2021
0
0
What does an ancient Greek monster have to do with treating cancer? As it turns out, quite a lot.
Mar 19, 2021
0
0
A new method, described in a study published today in the journal Nature Communications, has the potential to boost international research efforts to find drugs that eradicate cancer at its source.
Mar 1, 2021
0
74
Leading cancer experts at the University of Birmingham have solved a long-standing question of how various types of mutations in just one gene cause different types of diseases.
Jan 14, 2021
0
6
The stroma of the choroid plexus is one of the locations within the central nervous system (CNS) that serves as a shelter for tumor cells, allowing them to elude chemotherapy and potentially cause subsequent relapses in childhood ...
Sep 25, 2020
0
2
The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England. The National Institute for Health and Care Excellence (NICE) overturned their initial rejection of ...
Jul 17, 2020
0
2
Activating the immune system is a promising form of cancer treatment. Researchers at the University of Helsinki and Helsinki University Hospital as well as the University of Eastern Finland mapped out the immune landscape ...
Jul 9, 2020
0
99
Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine. The drug has not been successful, however, ...
Jun 24, 2020
0
1
Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML.
Jun 19, 2020
0
17
New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers.
Jun 15, 2020
0
80
Peter Mac scientists have found a way to target acute myeloid leukemia (AML) at its source—a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.
Dec 12, 2019
0
84